Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03869216 · ClinicalTrials.gov registry record · NA
Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men
A NA study of Prostate Cancer, sponsored by Xavier University of Louisiana..
- Completed
- Registry status
- NA
- Development phase
- 161
- Enrollment target
- 1
- Study location
NCT03869216: Completed NA study of Prostate Cancer, sponsored by Xavier University of Louisiana..
NCT03869216 is a NA study of Prostate Cancer that has completed, run by Xavier University of Louisiana.. The registered enrollment target is 161 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03869216, a NA study of Prostate Cancer, has completed, sponsored by Xavier University of Louisiana..
- COMPLETED
- Registry status
- NA
- Development phase
- 161 participants
- Enrollment target
- 1
- Study location
Study Summary
This behavioral clinical trial assesses the efficacy of a educational intervention to increase shared decision making about prostate-specific antigen (PSA)-based screening for prostate cancer among African American males. Half of participants will receive a multimedia educational intervention, while the other half will receive usual care.
Primary Outcome
The Observing Patient Involvement (OPTION) Scale was used for the coding of the SDM. The total OPTION scale ranges from 0 to 48. Higher values on the scale mean higher patient involvement in the decision-making process.
Conditions Studied
Interventions
- BEHAVIORAL Educational Shared Decision-Making Intervention
Study Locations (1)
Louisiana
- Tulane Medical Center - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2020-08-17 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT03869216 record still lists
NCT03869216 is an interventional study that assigns participants to a tested intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Educational Shared Decision-Making Intervention is the first listed.
NCT03869216 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT03869216 about?
NCT03869216 is a clinical study titled "Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men". This behavioral clinical trial assesses the efficacy of a educational intervention to increase shared decision making about prostate-specific antigen (PSA)-based screening for prostate cancer among African American males. Half of participants will receive a multimedia educational intervention, while...
What is the current status of trial NCT03869216?
This trial is currently completed. It is a NA study. The enrollment target is 161 participants. The study started on 2020-08-17. Estimated completion is 2023-12-31.
What conditions does trial NCT03869216 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT03869216?
The interventions under investigation include: Educational Shared Decision-Making Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03869216?
This trial is sponsored by Xavier University of Louisiana., which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03869216 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03869216's enrollment target sits among peer trials
161 253rd of 735 higher than 481 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06546670 · 161 participants · Phase 1
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- NCT06616766 · 161 participants · Phase 1
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- NCT06752356 · 161 participants · Phase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT07144826 · 161 participants · Early Phase 1
Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI